0
Letters |

Prenatal Cocaine Exposure as a Risk Factor for Later Developmental Outcomes—Reply

Deborah A. Frank, MD; Marilyn Augustyn, MD; Wanda Grant Knight, PhD; Tripler Pell, MSc; Barry Zuckerman, MD
JAMA. 2001;286(1):45-47. doi:10.1001/jama.286.1.45.
Text Size: A A A
Published online

Extract

In Reply: These correspondents share 2 concerns. The first is disagreement with our selection criteria for articles1—that the criteria were excessively stringent in restriction to human samples, peer review, masked assessment, and prospective recruitment, and simultaneously inadequately selective with respect to attrition and sample size. Animal studies are, as the thalidomide tragedy showed, unreliable indicators of a teratogenicity of a substance or its safety in humans. Methodologic issues also influence interpretation of animal data—whether cocaine effects are found varies by species, sex, timing of exposure, mode of administration, age at assessment, and whether control animals were pair fed with exposed animals.2 Except for the article by Leech et al,3 which was presented in detail in our review, the other articles with human subjects cited by Drs Stanwood and Levitt were in a non-peer–reviewed publication.4 Without the exposition of the methods demanded by a peer-reviewed journal, these works-in-progress cannot be interpreted with confidence. We make no apologies for excluding, in spite of large sample sizes, articles that lack prospective recruitment or masked assessment; these criteria were justified in detail in our review.1

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs